Trial intelligence / Profile preview

Azithromycin Dose-Ranging for Disseminated MAC in AIDS

NCT00002090Phase 2Completed

Sponsor
Pfizer
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of azithromycin in Mycobacterium avium complex infection (MAC), sponsored by Pfizer. Status: completed.

02

Drugs

azithromycin
03

Conditions

Mycobacterium avium complex infection (MAC)

Beyond the preview

Go deeper on NCT00002090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call